Business Ethics

A culture of integrity, accountability & transparency

At Fresenius Kabi we care for the life of patients worldwide. To fulfill our commitment to benefit critically and chronically ill patients, collaborating with physicians, hospitals and patient organizations is essential. These partnerships are not only required to develop products that best meet clinical needs. Healthcare Professionals are provided with the necessary expertise and education to be able to safely and effectively use our drugs and medical devices. In supporting medical research and education Fresenius Kabi contributes to patient safety and increased access to new technologies and services.

We expect transparency, accountability and high ethical standards from ourselves – and our stakeholders expect the same from us. Their trust is rewarded by acting with utmost integrity and responsibility. We believe that transparency is key to safeguard the integrity of these partnerships to the public and remain trusted.

Being a member of various industry associations in the countries we are operating in, we have committed ourselves to disclose certain value transfers to Healthcare Professionals, Healthcare Organizations and selected patient care organizations in these countries.

In each such interaction, we respect the obligation of Healthcare Professionals to make independent treatment decisions.

Below you will find an overview of value transfers made in the respective years:

 

Fresenius Kabi Ireland Limited Methodological Notes

2023 Methodological Notes for reporting- click here

2023 Transfer of Value for reporting- click here

2022 Methodological Notes for reporting- click here

2022 Transfer of Value for reporting- click here

2021 Methodological Notes for reporting- click here

2021 Transfer of Value for reporting- click here

This statement has been prepared in compliance with section 54 of the Modern Slavery Act 2015 to set out the steps that Fresenius Kabi UK has taken during its financial year ending in 2022 to prevent slavery and human trafficking from taking place in its business or any of its supply chain.
This statement has been approved by the UK Leadership Team on 30 June 2023.

To read the full Modern Slavery Statement click here

2023 Gender Pay Gap Report

Gender Pay Gap Report 2023

Fresenius Kabi Limited is required by law to publish an annual gender pay gap report. This is our report for the snapshot date of 5 April 2023.

  • The mean gender pay gap for Fresenius Kabi Limited is 9.2%
  • The median gender pay gap for Fresenius Kabi Limited is -9.1%
  • The mean gender bonus gap for Fresenius Kabi Limited is 20.4%
  • The median gender bonus gap for Fresenius Kabi Limited is 40.4%
  • The proportion of male employees in Fresenius Kabi Limited receiving a bonus is 93.1% and the proportion of female employees receiving a bonus is 91.4%

Pay Quarters by Gender

Band A – Upper Quarter

  • Males 43.3%
  • Females 56.7%

Includes all employees whose standard hourly rate places them in the upper pay quarter

Band B – Upper Middle Quarter

  • Males 22.7%
  • Females 77.3%

Includes all employees whose standard hourly rate places them in the upper middle pay quarter

Band C – Lower Middle Quarter

  • Males 46.2%
  • Females 53.8%

Includes all employees whose standard hourly rate places them in the lower middle pay quarter

Band D – Lower Quarter

  • Male 38.9%
  • Females 61.1%

Includes all employees whose standard hourly rate places them in the lower pay quarter.

The figures set out above have been calculated using the standard methodologies used in the Equality Act 2010 (Gender Pay Gap Information) Regulations 2017.

Fresenius Kabi Limited is committed to the principle of equal opportunities and equal treatment for all employees, regardless of sex, race, religion or belief, age, marriage or civil partnership, pregnancy/maternity, sexual orientation, gender reassignment or disability. It has a clear policy of paying employees equally for the same or equivalent work, regardless of their sex (or any other characteristic set out above).

Fresenius Kabi Limited is therefore confident that its gender pay group does not stem from paying men and women differently for the same or equivalent work. Rather its gender pay gap is the result of the roles in which men and women work within the organisation and the salaries that these roles attract.

I, Mikko Tiitinen, Managing Director (UK and Ireland), Fresenius Kabi Limited. Confirm that the information in this statement is accurate.

In accordance with UK legislations, Schedule 19 of Finance Act 2016, the company is publishing its tax strategy for the Year Ended 31st December 2022, which will be refreshed annually. We confirm that this strategy will apply to the following UK companies for all UK taxes: Note, this applicable for Northern Ireland only. 

  • Fresenius Kabi Limited 
  • Calea UK Limited 
  • FHC (Holdings) Limited
  • Fresenius Kabi Oncology plc
Approach to Tax Risk Management & Governance

We aim for our tax affairs to be compliant with UK tax legislation and the Board of Directors in the UK are committed to the delivery of tax compliance.
We employ the services of a professional tax advisor to prepare our Corporate Tax Computations and, Returns and to provide other services including tax technical updates and flagging new legislation to help reduce the risk of non-compliance. We also ensure that we employ appropriately qualified and experienced staff to prepare and submit relevant returns, for example VAT and PAYE.

Level of Tax Risk we are prepared to accept

Our appetite for tax risk is low and the UK Board of Directors sees compliance with tax legislation as key to managing our tax risk by using principals of reasonable.
Due to the size and complexity of the business there is an inherent degree of tax risk. We recognise that eliminating tax risk entirely is impossible, but we aim to manage our tax risk as far as practically possible.
In areas of uncertainty where tax risk arises from the complexity of tax legislation and differences in interpretation, we will seek appropriate external advice before engaging with HMRC.
Our approach is to aim to be compliant and understand our responsibilities with regard to tax and we will claim legitimate tax incentives, exemptions and reliefs offered by the UK Government to all tax payers.

Attitude towards Tax Planning

We will consider a range of tax outcomes based on the underlying commercial intention of any business activity or transaction that supports our business activities and the Group’s code of conduct, rather than looking for ways to aggressively avoid the payment of tax. We seek to balance the shareholders’ interest of managing business expenses, which include taxation, with ensuring that any arrangements comply with current UK tax legislation.
We have a responsibility to minimise our tax risk and our exposure to negative publicity through non-compliance.

Approach towards dealing with HMRC

We seek to ensure that our engagement with HMRC is professional, open and honest by having a co-operative and proactive working relationship with them. We also aim to undertake our filing requirements in a timely manner, by meeting relevant filing and payment deadlines for taxes that the company pays.



Job code: IE-FK-NPR-2400156

Date of preparation: November 2024